The authorization was granted to ImmunityBio, the manufacturer of Anktiva ® (nogapendekin alfa inbakicept-pmln), an interleukin-15 receptor agonist, indicated with BCG for adult patients with BCG ...
A new report released today, January 22, from Nasdaq and Boston Consulting Group (BCG), suggests that by embracing a systems-based approach powered by modern technologies like artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback